Absci Corp ABSI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/24/24 EDT
4.28quote price arrow up+0.07 (+1.66%)
Volume
26,952
Close
4.21quote price arrow down-0.14 (-3.22%)
Volume
848,156
52 week range
1.11 - 6.72
Loading...
  • Open4.43
  • Day High4.43
  • Day Low4.16
  • Prev Close4.35
  • 52 Week High6.72
  • 52 Week High Date04/09/24
  • 52 Week Low1.11
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap476.082M
  • Shares Out113.08M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change0.24

KEY STATS

  • Open4.43
  • Day High4.43
  • Day Low4.16
  • Prev Close4.35
  • 52 Week High6.72
  • 52 Week High Date04/09/24
  • 52 Week Low1.11
  • 52 Week Low Date10/26/23
  • Market Cap476.082M
  • Shares Out113.08M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change0.24

RATIOS/PROFITABILITY

  • EPS (TTM)-1.17
  • P/E (TTM)-3.61
  • Fwd P/E (NTM)-5.31
  • EBITDA (TTM)-79.264M
  • ROE (TTM)-44.20%
  • Revenue (TTM)5.347M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,042.01%
  • Debt To Equity (MRQ)3.07%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Absci Corp

 

Profile

MORE
Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of...
Sean Mcclain
Chief Executive Officer, Founder, Director
Zachariah Jonasson Ph.D.
Chief Financial Officer, Chief Business Officer, Treasurer
Address
18105 Se Mill Plain Blvd
Vancouver, WA
98683
United States

Top Peers

SYMBOLLASTCHG%CHG
CELC
Celcuity Inc
15.64-0.22-1.39%
ATXS
Astria Therapeutics Inc
9.02UNCHUNCH
IGMS
IGM Biosciences Inc
9.55-0.49-4.93%
OCGN
Ocugen Inc
1.75-0.03-1.69%
CMPS
Compass Pathways PLC
7.48+0.02+0.27%